Garo Megerian, MD is a medicare enrolled "Obstetrics & Gynecology - Maternal & Fetal Medicine" physician in Oaks, Pennsylvania. He went to Hahnemann University College Of Medicine and graduated in 1988 and has 36 years of diverse experience with area of expertise as Obstetrics/gynecology. He is a member of the group practice Regional Womens Health Group Llc and his current practice location is
450 Cresson Blvd, Ste. 300, Oaks, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at
(484) 831-0200.
Garo Megerian is licensed to practice in Pennsylvania (license number MD043261L) and he also participates in the medicare program. He
accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1982652921.
Physician's Profile
Full Name | Garo Megerian |
---|
Gender | Male |
---|
Speciality | Obstetrics/gynecology |
---|
Experience | 36 Years |
---|
Location | 450 Cresson Blvd, Oaks, Pennsylvania |
---|
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Medical Education and Training:
- Garo Megerian attended and graduated from Hahnemann University College Of Medicine in 1988
NPI Data:
- NPI Number: 1982652921
- Provider Enumeration Date: 05/04/2006
- Last Update Date: 07/06/2021
Medicare PECOS Information:
- PECOS PAC ID: 1456321629
- Enrollment ID: I20040727000929
Medical Identifiers
Medical identifiers for Garo Megerian such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1982652921 | NPI | - | NPPES |
531740 | Other | PA | BC/BS SHIELD HIGHMARK |
02640 | Other | PA | HEALTH PARTNERS |
0012897910021 | Medicaid | PA | |
1652893 | Other | PA | BC/BS HIGHMARK GROUP |
0218979116 | Other | PA | AMERICHOICE |
33657 | Other | PA | HEALTH PARTNERS |
33658 | Other | PA | HEALTH PARTNERS |
33659 | Other | PA | HEALTH PARTNERS |
30018990 | Other | PA | KEYSTONE MERCY |
4459215 | Other | PA | AETNA US HEALTHCARE |
0734800000 | Other | PA | BC/BS KEY, PER. GROUP |
30018989 | Other | PA | KEYSTONE MERCY GROUP |
3716964 | Other | PA | AETNA US HEALTHCARE HMO |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
207VM0101X | Obstetrics & Gynecology - Maternal & Fetal Medicine | MD043261L (Pennsylvania) | Primary |
Group Practice Association
Group Practice Name | Group PECOS PAC ID | No. of Members |
Regional Womens Health Group Llc | 2961316328 | 323 |
Medicare Reassignments
Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Garo Megerian allows following entities to bill medicare on his behalf.
Entity Name | Main Line Healthcare |
---|
Entity Type | Part B Supplier - Clinic/group Practice |
---|
Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
---|
Entity Name | Regional Womens Health Group Llc |
---|
Entity Type | Part B Supplier - Clinic/group Practice |
---|
Entity Identifiers | NPI Number: 1750880118 PECOS PAC ID: 2961316328 Enrollment ID: O20180611002120 |
---|
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Garo Megerian is
enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Garo Megerian, MD Po Box 22581, New York, NY 10087-2581 Ph: (610) 482-4795 | Garo Megerian, MD 450 Cresson Blvd, Ste. 300, Oaks, PA 19456 Ph: (484) 831-0200 |
Reviews and Comments